142 related articles for article (PubMed ID: 31401046)
1. SHARPIN Promotes Melanoma Progression via Rap1 Signaling Pathway.
Zhou S; Liang Y; Zhang X; Liao L; Yang Y; Ouyang W; Xu H
J Invest Dermatol; 2020 Feb; 140(2):395-403.e6. PubMed ID: 31401046
[TBL] [Abstract][Full Text] [Related]
2. BET inhibitor suppresses melanoma progression
Deng G; Zeng F; Su J; Zhao S; Hu R; Zhu W; Hu S; Chen X; Yin M
Theranostics; 2020; 10(25):11428-11443. PubMed ID: 33052224
[No Abstract] [Full Text] [Related]
3. Activation of nuclear factor κB pathway and downstream targets survivin and livin by SHARPIN contributes to the progression and metastasis of prostate cancer.
Zhang Y; Huang H; Zhou H; Du T; Zeng L; Cao Y; Chen J; Lai Y; Li J; Wang G; Guo Z
Cancer; 2014 Oct; 120(20):3208-18. PubMed ID: 24925528
[TBL] [Abstract][Full Text] [Related]
4. SHARPIN overexpression promotes TAK1 expression and activates JNKs and NF-κB pathway in Mycosis Fungoides.
Chen B; Zheng Y; Zhu J; Liang Y
Exp Dermatol; 2019 Nov; 28(11):1279-1288. PubMed ID: 31461795
[TBL] [Abstract][Full Text] [Related]
5.
Siitonen R; Peuhu E; Autio A; Liljenbäck H; Mattila E; Metsälä O; Käkelä M; Saanijoki T; Dijkgraaf I; Jalkanen S; Ivaska J; Roivainen A
J Nucl Med; 2019 Oct; 60(10):1380-1387. PubMed ID: 30850498
[TBL] [Abstract][Full Text] [Related]
6. The Tumor-Promoting Role of TRIP4 in Melanoma Progression and its Involvement in Response to BRAF-Targeted Therapy.
Hao J; Xu H; Luo M; Yu W; Chen M; Liao Y; Zhang C; Zhao X; Jiang W; Hou S; Feng X; Zou K; Chen Y; Huang W; Guo W; Kang L; Deng W
J Invest Dermatol; 2018 Jan; 138(1):159-170. PubMed ID: 28899685
[TBL] [Abstract][Full Text] [Related]
7. Elevation of SHARPIN Protein Levels in Prostate Adenocarcinomas Promotes Metastasis and Impairs Patient Survivals.
Huang H; Du T; Zhang Y; Lai Y; Li K; Fan X; Zhu D; Lin T; Xu K; Huang J; Liu L; Guo Z
Prostate; 2017 May; 77(7):718-728. PubMed ID: 28230260
[TBL] [Abstract][Full Text] [Related]
8. SHARPIN regulates cell proliferation of cutaneous basal cell carcinoma via inactivation of the transcriptional factors GLI2 and c‑JUN.
Yang Y; Liang YH; Zheng Y; Tang LJ; Zhou ST; Zhu JN
Mol Med Rep; 2020 Apr; 21(4):1799-1808. PubMed ID: 32319607
[TBL] [Abstract][Full Text] [Related]
9. A novel gammaretroviral shuttle vector insertional mutagenesis screen identifies SHARPIN as a breast cancer metastasis gene and prognostic biomarker.
Bii VM; Rae DT; Trobridge GD
Oncotarget; 2015 Nov; 6(37):39507-20. PubMed ID: 26506596
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis.
Ci C; Tang B; Lyu D; Liu W; Qiang D; Ji X; Qiu X; Chen L; Ding W
Int J Mol Med; 2019 Jan; 43(1):404-412. PubMed ID: 30431060
[TBL] [Abstract][Full Text] [Related]
11. AFF4 facilitates melanoma cell progression by regulating c-Jun activity.
Hu H; Zhang Y; Zhao L; Zhao W; Wang X; Ye E; Dong Y; Zhang L; Ran F; Zhou Y; Huang Y
Exp Cell Res; 2021 Feb; 399(2):112445. PubMed ID: 33417923
[TBL] [Abstract][Full Text] [Related]
12. SHARPIN-mediated regulation of protein arginine methyltransferase 5 controls melanoma growth.
Tamiya H; Kim H; Klymenko O; Kim H; Feng Y; Zhang T; Han JY; Murao A; Snipas SJ; Jilaveanu L; Brown K; Kluger H; Zhang H; Iwai K; Ronai ZA
J Clin Invest; 2018 Jan; 128(1):517-530. PubMed ID: 29227283
[TBL] [Abstract][Full Text] [Related]
13. Ras-associated protein-1 regulates extracellular signal-regulated kinase activation and migration in melanoma cells: two processes important to melanoma tumorigenesis and metastasis.
Gao L; Feng Y; Bowers R; Becker-Hapak M; Gardner J; Council L; Linette G; Zhao H; Cornelius LA
Cancer Res; 2006 Aug; 66(16):7880-8. PubMed ID: 16912161
[TBL] [Abstract][Full Text] [Related]
14. microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB.
Giles KM; Brown RA; Ganda C; Podgorny MJ; Candy PA; Wintle LC; Richardson KL; Kalinowski FC; Stuart LM; Epis MR; Haass NK; Herlyn M; Leedman PJ
Oncotarget; 2016 May; 7(22):31663-80. PubMed ID: 27203220
[TBL] [Abstract][Full Text] [Related]
15. High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma.
Guo H; Cheng Y; Martinka M; McElwee K
Oncotarget; 2015 Sep; 6(28):25484-98. PubMed ID: 26329521
[TBL] [Abstract][Full Text] [Related]
16. RASSF8 regulates progression of cutaneous melanoma through nuclear factor-κb.
Wang J; Hua W; Huang SK; Fan K; Takeshima L; Mao Y; Hoon DS
Oncotarget; 2015 Oct; 6(30):30165-77. PubMed ID: 26334503
[TBL] [Abstract][Full Text] [Related]
17. The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells.
Jenkins MH; Croteau W; Mullins DW; Brinckerhoff CE
Matrix Biol; 2015 Oct; 48():66-77. PubMed ID: 25989506
[TBL] [Abstract][Full Text] [Related]
18. EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation.
Mo SJ; Hou X; Hao XY; Cai JP; Liu X; Chen W; Chen D; Yin XY
Cancer Commun (Lond); 2018 Apr; 38(1):9. PubMed ID: 29764501
[TBL] [Abstract][Full Text] [Related]
19. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
[TBL] [Abstract][Full Text] [Related]
20. LncRNA FOXD3-AS1 promotes proliferation, invasion and migration of cutaneous malignant melanoma via regulating miR-325/MAP3K2.
Chen X; Gao J; Yu Y; Zhao Z; Pan Y
Biomed Pharmacother; 2019 Dec; 120():109438. PubMed ID: 31541886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
